Featured Post
NEWS FROM SWEDEN: First delivery of extemporaneous medicinal products manufactured using 3D technology
First delivery of extemporaneous medicinal products manufactured using 3D technology
Apotek Produktion och Laboratorier AB (APL), one of the largest manufacturers of compounded medicines and a leading Contract Development and Manufacturing Organization (CDMO) in Sweden, announces its first delivery of a compounded medicine produced by 3D-printing technology. APL applies 3D-printing technology within the concept ExtempoPrint.
How 3D Printing is Transforming Pharmaceuticals into More Precise, Effective Treatments
In this recent article, the future of 3D printed medicine in personalization of treatments is discussed. Here are some snap shots from the article.
Mass Customization of Medicines
Mass customization is required for optimal treatments of the future. This excellent article by Siiskonen, Malmqvist and Folestad (2021) describes the potentoal of mass customization.
Meet the team - interview with our CEO Charlotta
I’m a serial entrepreneur with a commercial background and I really like to learn new things and think outside of the box.
Potential Risks of Pharmacy Compounding
Why do we need quality assurance for pharmacy compounding in the future?
.jpg)
Introducing Our Team - Interviewing Niklas Sandler Topelius
Meet Niklas Sandler Topelius, the inventor of Curify's technology!